Division of Cardiology, Pulmonology, and Vascular Medicine.
Department of Cardiovascular Surgery.
J Heart Lung Transplant. 2015 Jul;34(7):921-32. doi: 10.1016/j.healun.2015.03.004. Epub 2015 Mar 24.
The hemodynamic vascular consequences of implanting left ventricular assist devices (LVADs) have not been studied in detail. We investigated the effect of LVAD implantation compared with heart transplant (HTx) on microvascular and macrovascular function in patients with end-stage heart failure and evaluated whether microparticles may play a role in LVAD-related endothelial dysfunction.
Vascular function was assessed in patients with end-stage heart failure awaiting HTx, patients who had undergone implantation of a continuous-flow centrifugal LVAD, and patients who had already received a HTx. Macrovascular function was measured by flow-mediated vasodilation (FMD) using high-resolution ultrasound of the brachial artery. Microvascular function was assessed in the forearm during reactive hyperemia using laser Doppler perfusion imaging and pulsed wave Doppler. Age-matched patients without heart failure and without coronary artery disease (CAD) (healthy control subjects) and patients with stable CAD served as control subjects. Circulating red blood cell (CD253(+)), leukocyte (CD45(+)), platelet (CD31(+)/CD41(+)), and endothelial cell (CD31(+)/CD41(-), CD62e(+), CD144(+)) microparticles were determined by flow cytometry and free hemoglobin by enzyme-linked immunosorbent assay.
FMD and microvascular function were significantly impaired in patients with end-stage heart failure compared with healthy control subjects and patients with stable CAD. LVAD implantation led to recovery of microvascular function, but not FMD. In parallel, increased free hemoglobin was observed along with red and white cell microparticles and endothelial and platelet microparticles. This finding indicates destruction of blood cells with release of hemoglobin and activation of endothelial cells. HTx and LVAD implantation led to similar improvements in microvascular function. FMD increased and microparticle levels decreased in patients with HTx, whereas shear stress during reactive hyperemia was similar in patients with LVADs and patients with HTx.
Our data suggest that LVAD support leads to significant improvements in microvascular perfusion and hemodynamics. However, destruction of blood cells may contribute to residual endothelial dysfunction potentially by increasing nitric oxide scavenging capacity.
左心室辅助装置(LVAD)植入后的血流动力学血管后果尚未得到详细研究。我们研究了与心脏移植(HTx)相比,LVAD 植入对终末期心力衰竭患者微血管和大血管功能的影响,并评估了微粒是否可能在 LVAD 相关的内皮功能障碍中发挥作用。
评估等待 HTx 的终末期心力衰竭患者、已植入连续流离心式 LVAD 的患者和已接受 HTx 的患者的血管功能。肱动脉高分辨率超声测量血流介导的血管扩张(FMD)来评估大血管功能。前臂在反应性充血期间使用激光多普勒灌注成像和脉冲波多普勒评估微血管功能。与无心力衰竭且无冠状动脉疾病(CAD)的年龄匹配患者(健康对照组)和稳定 CAD 患者一起作为对照组。通过流式细胞术测定循环红细胞(CD253(+))、白细胞(CD45(+))、血小板(CD31(+)/CD41(+))和内皮细胞(CD31(+)/CD41(-)、CD62e(+)、CD144(+))微粒,通过酶联免疫吸附试验测定游离血红蛋白。
与健康对照组和稳定 CAD 患者相比,终末期心力衰竭患者的 FMD 和微血管功能明显受损。LVAD 植入导致微血管功能恢复,但 FMD 未恢复。同时,观察到游离血红蛋白增加,以及红细胞和白细胞微粒、内皮细胞和血小板微粒增加。这一发现表明血细胞破坏导致血红蛋白释放和内皮细胞激活。HTx 和 LVAD 植入导致微血管功能相似的改善。HTx 患者的 FMD 增加,微粒水平降低,而 LVAD 患者和 HTx 患者的反应性充血期间的切应力相似。
我们的数据表明,LVAD 支持可显著改善微血管灌注和血液动力学。然而,血细胞破坏可能通过增加一氧化氮清除能力导致残余内皮功能障碍。